ADDXF Message Board Post 9779366 | Addex Pharms Ltd Ord
home / stock / addxf / addxf message board
kenta23
(investorshub)
Posted on: Oct/04/2011 07:55:40
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=67654267
Addex to Present Progress on Multiple Allosteric Modulator
News, Short Squeeze, Breakout and More Instantly...
-
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 15, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological...
-
Geneva, Switzerland, July 12, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that Mikhail Kalinichev, Head of T...
-
● GABAB PAM: Selection of drug candidates under Indivior collaboration expected by end of Q2 2024 . Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutic...